Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lesogaberan for chronic cough
2014-005074-11Phase 2Completed
- Sponsor
- Manchester University NHS Foundation Trust
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic cough comparing Lesogaberan arm with Placebo arm (2 arms). Primary endpoint: 24-hour objective cough frequency after 2 weeks of treatment. Started Mar 2015; status: completed.
02
Drugs
lesogaberan
03
Conditions
chronic cough
Beyond the preview
Go deeper on 2014-005074-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005074-11.